Rebif New Zealand - English - Medsafe (Medicines Safety Authority)

rebif

pharmacy retailing (nz) ltd t/a healthcare logistics - interferon beta-1a 44 µg/ml (6miu per 0.5ml dose);   - solution for injection - 22 mcg/0.5ml - active: interferon beta-1a 44 µg/ml (6miu per 0.5ml dose)   excipient: acetic acid benzyl alcohol mannitol methionine poloxamer sodium hydroxide water for injection - o ambulatory patients with multiple sclerosis who have experienced two or more relapses within the last 2 years.

Extavia European Union - English - EMA (European Medicines Agency)

extavia

novartis europharm limited - interferon beta-1b - multiple sclerosis - immunostimulants, - extavia is indicated for the treatment of:patients with a single demyelinating event with an active inflammatory process, if it is severe enough to warrant treatment with intravenous corticosteroids, if alternative diagnoses have been excluded, and if they are determined to be at high risk of developing clinically definite multiple sclerosis;patients with relapsing-remitting multiple sclerosis and two or more relapses within the last two years;patients with secondary progressive multiple sclerosis with active disease, evidenced by relapses.

Betaferon Namibia - English - Namibia Medicines Regulatory Council

betaferon

bayer (pty) ltd - interferon beta - injection - each 3 ml solution contains interferon beta 0,3 mg